T1	Concept 11 19	COVID-19
T2	Concept 20 28	patients
R1	has-property Arg1:T2 Arg2:T1	
T3	Concept 4 7	age
R2	in-context Arg1:T3 Arg2:T2	
T4	Concept 93 97	male
T5	Action 107 118	susceptible
A1	Emphasized T5
T6	Concept 128 134	female
R3	subject Arg1:T5 Arg2:T4	
R4	target Arg1:T5 Arg2:T6	
T7	Concept 166 192	yeast linear pGKL plasmids
T8	Concept 297 332	linear double-stranded DNA plasmids
T9	Action 287 296	localized
T10	Concept 265 286	yeast cytoplasmically
R5	target Arg1:T9 Arg2:T8	
T11	Concept 333 338	PARP2
T12	Action 339 348	maintains
T13	Concept 349 366	genomic stability
